Vini Mani

Vini Mani is a Senior Principal at Flagship Pioneering. In this role, she works across the life cycle of emerging ventures in the life sciences with a team of entrepreneurial scientists to explore new areas of biology and create and grow Flagship’s first-in-class platforms. At Flagship, Vini co-founded ProFound Therapeutics in 2020 and serves as Chief Innovation Officer leading the advancement of the ProFoundry Platform to unlock the potential of the expanded human proteome.

Prior to joining Flagship, Vini completed her doctoral studies in Immunology at Harvard Medical School, where her thesis work uncovered a novel stage of T cell differentiation and contributed to advancing cancer immunology and barrier immunity, resulting in publications in Science, Cell, and Nature and earning multiple awards including the Janeway Award from the American Association of Immunologists. While in graduate school, Vini was a member of the founding team and Director of Product Development at Adeo Health Science, a Boston-based startup focused on the prevention of allergy development in children. Vini also devoted significant time to cultivating the next generation of scientists, as Co-Director of Science in the News, an organization that provides a platform for graduate students to refine their communication skills and effectively engage with diverse public audiences. She remains an active member of the Harvard alumni community, contributing through teaching and mentoring initiatives. Vini also serves on the board of Science Club for Girls, an organization promoting STEM education and literacy in under-represented populations

Vini holds a Ph.D. in Immunology from Harvard Medical School and a B.S. in Bioengineering with a Certificate in Entrepreneurship and Technology from the University of California, Berkeley.